Pharma Research Products acquires Aestura’s Filler (CLEVIEL®) Business Division > News

PR Center

A biopharmaceutical firm realizing regenerative medicine

News

News

Pharma Research Products acquires Aestura’s Filler (CLEVIEL®) Business…

페이지 정보

Date18-09-17 02:58 Number of views222

본문



0217918e4cd405daf7a51d52a60c3ca8_1539142938_6023.jpg
 

 

Pharma Research Products Co., Ltd., a company that continues to grow in the field of cosmetic products such as D+CELL 350® TRA, REJURAN® Healer signed a binding MOU with Amorepacific Group subsidiary, Aestura Corporation (Filler business division) following recently signed binding MOU of botulinum toxin company, Bio C&D. It will accelerate the expansion of the aesthetic business. The acquisition of filler business division of Aestura Corporation will transfer technology and goodwill related to the HA filler brand ‘CLEVIEL®’ and the contract will be concluded in February 2018.